CD8A and neoplasm: They stimulate the adaptive immune system by binding to homologous receptors on innate immune cells, such as dendritic cells (DCs), leading to tumor antigen-specific CD8+ T cell-mediated immune responses that eliminate residual cancer cells and establish immune-resident memory T cells [18].